September 2, 2026 – VivoSim Labs, Inc. (NASDAQ: VIVS) is expanding the potential commercial reach of its NAMkind™ drug toxicology platform, announcing plans to develop a rat liver model that would complement its existing 3D human liver model and help pharmaceutical companies … Continue reading →

NEW YORK, September 1, 2026 — Emerging-growth stocks bioAffinity Technologies, Inc. (NASDAQ: BIAF), AEye, Inc. (NASDAQ: LIDR), Sono Group N.V. (NASDAQ: SSM), and Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) are in focus following developments across lung cancer diagnostics, space … Continue reading →

NEW YORK, September 1, 2026 — Micro-cap and emerging-growth stocks GoPro, Inc. (NASDAQ: GPRO), Fly-E Group, Inc. (NASDAQ: FLYE), Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD) and VivoSim Labs, Inc. (NASDAQ: VIVS) are drawing investor attention across AI infrastructure, electric mobility, … Continue reading →

September 01, 2026 Emerging-growth companies spanning Physical AI, wearable robotics, livestreaming e-commerce, AI infrastructure, data centers, GPU computing and digital assets are drawing investor attention as companies pursue opportunities tied to the expanding digital economy. Among stocks to watch are Wetour Robotics … Continue reading →

September 01, 2026 Several small-cap stocks are drawing investor attention following new corporate developments spanning biotechnology, military robotics, real estate and AI-enabled travel, with RedHill Biopharma Ltd. (NASDAQ: RDHL), Peraso Inc. (NASDAQ: PRSO), LogProstyle Inc. (NYSE: LGPS) and Webuy Global Ltd. (NASDAQ: … Continue reading →

September 01, 2026 IGC Pharma, Inc. (NYSE: IGC) is gaining attention after Ascendiant Capital Markets raised its 12-month price target to $6.00 from $5.50 while maintaining its BUY rating, citing continued clinical progress and the Company’s expanding AI-enabled Alzheimer’s programs. The … Continue reading →